<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"German cancer registry data":1,
"Hodgkin lymphoma":2,
"non-Hodgkin lymphoma":1,
"standardized incidence ratio":1,
"subsequent primary malignancies":1,
"nodules":1,
"pathology":1,
"thyroid":11,
"ultrasound":3,
"2SC":1,
"BAP1":1,
"BAP1 hereditary cancer predisposition syndrome":1,
"Carney complex":1,
"FAP-associated cribriform-morular variant of papillary thyroid carcinoma":1,
"Familial succinate dehydrogenase-related pheochromocytoma/paraganglioma":1,
"Fumarate hydratase":1,
"Glucagon":1,
"HLRCC":1,
"HPT-JT":1,
"HRASQ61R":1,
"MEN2":1,
"Mahvash disease":1,
"PRKAR1A":1,
"Pancreatic neuroendocrine tumor syndrome":1,
"Parafibromin":1,
"SDHB":1,
"β-catenin":1,
"Tyrosine kinase inhibitors":2,
"meta-analysis":4,
"radioiodine refractory":1,
"targeted therapy":1,
"thyroid cancer":23,
"Diabetes":2,
"Diet":1,
"Milk":1,
"Obesity":1,
"Thyroid nodules":5,
"Second malignancy":1,
"cancer survivorship":1,
"cohort study":1,
"levothyroxine":1,
"osteoporosis":1,
"Classification":1,
"Indeterminate fine-needle aspiration cytology":1,
"Thyroid nodule":9,
"Breast neoplasm":1,
"Estrogen receptor":1,
"Human epidermal growth factor receptor 2":1,
"Ki-67":1,
"Progesterone receptor":1,
"Staging":1,
"Laryngectomy":1,
"computed tomography scan":1,
"computerized axial tomography scan":1,
"squamous cell carcinoma":2,
"thyroid gland":3,
"thyroidectomy":8,
"18F-FDG":1,
"2-deoxy-2-(18F)fluoro-d-glucose":1,
"medullary thyroid carcinoma":2,
"positron emission tomography":1,
"tyrosine kinase inhibitor":1,
"vandetanib":3,
"FDG":1,
"PET/CT":1,
"incidentaloma":1,
"oncology":1,
"benign":1,
"cyst":1,
"fine-needle aspiration":2,
"ultrasonography":6,
"TSH suppression":2,
"hyperinsulinemic-euglycemic clamp":1,
"insulin sensitivity":1,
"MIVAT":1,
"Scar":1,
"Tips and techniques":1,
"Bilateral axillo-breast approach":1,
"Lymph node metastasis":3,
"Modified radical neck dissection":1,
"Papillary thyroid carcinoma":18,
"Thyroid carcinoma":7,
"Gynecologic cancer":1,
"Rare cancer":1,
"CASTLE":1,
"EGFR":2,
"EGFR T790M":1,
"sequencing":1,
"thyroiditis":2,
"Genetic markers":1,
"Proto-oncogene":1,
"Cervical lymph node":1,
"Cáncer de tiroides diferenciado":1,
"Differentiated thyroid carcinoma":2,
"Disección de ganglios del cuello":1,
"Ganglio cervical":1,
"Metastasis":4,
"Metástasis":1,
"Neck lymph node dissection":1,
"Patient Care":1,
"Practice-Based Learning and Improvement":1,
"Systems-Based Practice":1,
"curriculum":1,
"fine needle aspiration":3,
"simulation":1,
"thyroid biopsy":1,
"CK20":1,
"MCPyV":1,
"Merkel cell carcinoma":2,
"TTF-1":1,
"differential diagnosis":1,
"lymph nodes":1,
"neuroendocrine carcinoma":1,
"Anterior pituitary":1,
"Diabetes insipidus":1,
"Glucose metabolism":2,
"Langerhans cell histiocytosis":1,
"operative time":1,
"robotic thyroidectomy":1,
"thyroid surgery":1,
"thyroid tumor":1,
"NIFTP":2,
"follicular adenoma":1,
"metaplasia":1,
"papillary carcinoma":2,
"spindle cell":1,
"Breast cancer":7,
"TERT promoter mutation":3,
"Telomerase reverse transcriptase":1,
"IC87114":1,
"PI3K/Akt":1,
"docetaxel":1,
"epirubicin":1,
"neoadjuvant chemotherapy":1,
"recombinant human endostatin (endostar)":1,
"robotic":1,
"transoral":1,
"anaplastic thyroid cancer":1,
"autophagy":1,
"digitalislike compounds":1,
"hNIS":1,
"radioactive iodide":1,
"apoptos":1,
"cell signaling pathways":1,
"EMT":1,
"PTC":1,
"apoptosis":2,
"invasion":2,
"SEER":1,
"disease specific survival":1,
"extent of operation":1,
"medullary thyroid cancer":2,
"gasless trans-axillary approach":1,
"outcome":1,
"periodic change":1,
"robotic surgery":1,
"illness perceptions":1,
"interpretative phenomenological analysis":1,
"psychosocial":1,
"support needs":1,
"young people":1,
"AKT2":1,
"Lung metastasis":2,
"Migration and invasion":1,
"Ovarian cancer":3,
"PKM2":2,
"Leiomyosarcoma":1,
"Parotid gland":1,
"Parotidectomy":1,
"Autocrine":1,
"Diagnostic":1,
"Metastases":2,
"Oncogene":1,
"PDGFR α":1,
"Platelet derived growth factor α":1,
"Atypia of undetermined significance":1,
"Bethesda thyroid cytopathology system":1,
"Follicular lesion of undetermined significance":1,
"Papillary features":1,
"Afirma":1,
"atypia of undetermined significance (AUS)":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"subcategory":1,
"FGF19":1,
"FGFR4":1,
"Serum concentration":1,
"βKlotho":1,
"Clinicopathological features":2,
"Lymph node dissection":3,
"Neoplasm recurrence, local":1,
"Thyroid cancer, well differentiated, papillary, follicular":1,
"Tumor staging":1,
"BNCT":1,
"Damage":1,
"Pathways":1,
"Repair":1,
"7-gene test":1,
"Bethesda system":2,
"atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS)":1,
"diagnostic qualifiers":1,
"molecular diagnosis":1,
"thyroid fine-needle aspiration (FNA)":1,
"CXCL5-CXCR2 axis":1,
"Cancer metastasis":1,
"Epithelial-to-mesenchymal transition":1,
"β-catenin signaling":1,
"Contrast-enhanced ultrasound":1,
"Solid hypo-echoic thyroid nodules":1,
"Thyroid Imaging Reporting and Data System":1,
"HOTTIP":1,
"Long non-coding RNA":2,
"Migration":1,
"Proliferation":2,
"miR-637":1,
"Nordic registries":1,
"Pregnancy":1,
"colorectal cancer":1,
"endometrial cancer":1,
"Radioresistance":1,
"Stem-like":1,
"Air pollution":1,
"Cancer":4,
"Incidence":5,
"Industrial waste gas":1,
"Shanghai":1,
"Follicular cancer":1,
"Papillary cancer":1,
"incidental":1,
"Italy":1,
"Mortality":1,
"Overdiagnosis":1,
"Time trends":1,
"cancer immunoediting":1,
"immune landscape":1,
"next generation sequencing":1,
"papillary thyroid cancer":7,
"tumor microenvironment":1,
"annual percent change":1,
"delay adjustment":1,
"early cancer rate estimates by race":1,
"early estimates of cancer incidence rates":1,
"population-based registry data":1,
"TSHR gene mutations":1,
"allelic frequency of TSHR gene mutations":1,
"cancer risks and TSHR mutation":1,
"follicular thyroid cancer and TSHR":1,
"Bexarotene":1,
"cancer prevention":1,
"cancer treatment":1,
"drug resistance":1,
"drug response":1,
"131I treatment":1,
"Contact time restrictions":1,
"Differentiated thyroid cancer (DTC)":1,
"Radiation safety":1,
"Radioiodine clearance":1,
"Radiosensitivity":1,
"cancers":1,
"cataracts":1,
"history of radiology":1,
"tissue reactions":1,
"Lymphoepithelial cyst":1,
"PAX8":1,
"Solid cell nest":1,
"Squamous metaplasia":1,
"Fine-needle biopsy":1,
"Otolaryngology":1,
"Thyroglobulin":2,
"anti-thyroglobulin antibodies":1,
"heterophile antibodies":1,
"immunometric assays":1,
"mass spectrometry":1,
"radioimmunoassay":1,
"thyroglobulin in washout":1,
"Image fusion":1,
"Optical camera":1,
"Radioiodine therapy":2,
"Whole-body scintigraphy":1,
"l-thyroxine":1,
"COX-2":1,
"PD-L1":2,
"resveratrol":1,
"papillary thyroid cancer surgery":1,
"persistent thyroid cancer":1,
"radioiodine":1,
"BRAF mutation":3,
"Cáncer papilar de tiroides":1,
"Factor pronóstico":1,
"Mutación BRAF":1,
"Prognostic factor":1,
"Terapia con (131)I":1,
"Lung adenocarcinoma":1,
"Lung cancer":1,
"TRIP13":1,
"Thyroid hormone receptor interactor 13":1,
"Thyroid neoplasm":1,
"carcinoembryonic antigen":1,
"carcinoma":1,
"lymph node metastases":1,
"medullary":2,
"node dissection":1,
"PDZ and LIM domain 5":1,
"Proteomics":1,
"Body mass index":1,
"height":1,
"weight":2,
"diagnostic category":1,
"indeterminate cytology":1,
"Combined merkel cell carcinoma":1,
"Merkel cell polyomavirus":1,
"Papillomavirus":1,
"Polyomavirus":1,
"Squamous carcinoma":1,
"AZD5153":1,
"BRD4":1,
"Cell proliferation":1,
"Molecularly-targeted therapy":1,
"Laryngotracheal reconstruction":1,
"PHACE syndrome":1,
"Subglottic hemangioma":1,
"Encapsulated follicular variant of papillary thyroid carcinoma":1,
"Fine-needle aspiration cytology":1,
"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features":2,
"Risk of malignancy":2,
"International trends":1,
"TI-RADS":1,
"thyroid guidelines":1,
"thyroid ultrasound":1,
"CD147":1,
"cell malignancy":1,
"miR-125a-5p":1,
"Latin America":1,
"epidemiology":2,
"trends":1,
"young adults":1,
"The Bethesda System for Reporting Thyroid Cytopathology":1,
"fine-needle aspiration biopsy":1,
"squamous cells":1,
"BRAF- and RAS-like tumors":1,
"DNA methylation":1,
"kallikrein-related peptidases":1,
"prognostic algorithm":1,
"thyroid cancer stratification":1,
"Gene therapy":1,
"Immunotherapy":1,
"Molecular imaging":1,
"Radioactive iodine refractory differentiated thyroid cancer":1,
"Targeted chemotherapy":1,
"BRAF V600E":1,
"Immunohistochemistry":4,
"PD-1":1,
"celecoxib":1,
"ultrastructural changes":1,
"Bad":1,
"Bax":1,
"Bcl-2":1,
"Benign thyroid nodules":1,
"gene expression":1,
"Cabozantinib":1,
"Metastatic":1,
"Multikinase":1,
"REMS":1,
"Calcitonin":1,
"Procalcitonin":1,
"Imaging analysis":1,
"Imaging feature":1,
"Imaging pattern":1,
"Malignancy risk":1,
"Nodule size":1,
"Pattern analysis":1,
"Thyroid malignancy":1,
"Tumor size":1,
"Thyroxine":1,
"hepatocellular carcinoma":3,
"thyroid stimulating hormone":2,
"Differentiation":1,
"H2O2":1,
"Iodide uptake":1,
"NKX2 5":1,
"Persistence/recurrence":1,
"thyroid disease":1,
"nicotinamide phosphoribosyltransferase":1,
"prognosis":3,
"BRAF-activated non-protein coding RNA":1,
"reverse transcription-quantitative polymerase chain reaction":1,
"cluster of differentiation 163":1,
"cluster of differentiation 68":1,
"folate receptor β":1,
"macrophage":1,
"follicular thyroid carcinoma":2,
"muscle metastasis":1,
"occult metastasis":1,
"occult thyroid carcinoma":1,
"Lymph node excision":1,
"Papillary thyroid microcarcinoma":1,
"Hepatocellular carcinoma TGF-β1 HMGCoAR Statins":1,
"MAP Kinase Signaling System":1,
"Proto-Oncogene Proteins B-raf":1,
"Thyroid Neoplasms":4,
"mitochondria":1,
"respiratory chain complex I":1,
"Laser":1,
"Radiofrequency":1,
"Thyroid ablation":1,
"age-related macular degeneration":1,
"national health insurance research database":1,
"Glucose":1,
"Glutamate oxaloacetate transaminase 1":1,
"Glycolysis":1,
"Metabolic regulation":1,
"Redox regulation":1,
"mTOR":1,
"sodium iodide symporter (NIS)/SLC5A5":1,
"Diagnosis":2,
"Frozen section":1,
"Intraoperative consultation of pathology":1,
"Telepathology":1,
"Congenital abnormalities":1,
"Diagnostic errors":1,
"Otorhinolaryngologic surgical procedures":1,
"Pyriform sinus fistula":1,
"Female":1,
"TSH supression therapy":1,
"Follow-up":1,
"Recurrence":1,
"Surveillance":1,
"Total thyroidectomy":2,
"cancer epidemiology":1,
"cohort studies":1,
"epidemiological methods":1,
"radiation":1,
"primary thyroid paraganglioma":1,
"treatment":1,
"cadmium":1,
"endocrine disruption":1,
"mechanisms":1,
"RECIST":1,
"systematic review":1,
"Late complication":1,
"Nasopharyngeal carcinoma":1,
"Normal tissue complication probability":1,
"Radiation-induced hypothyroidism":1,
"Radiotherapy":1,
"Calmodulin antagonists":1,
"Sec62 protein":1,
"Trifluoperazine":1,
"endoplasmic reticulum":1,
"tumor therapy":1,
"MPPED2":1,
"carcinogenesis":1,
"tumour suppressor":1,
"Carcinoid tumor":1,
"Diagnosis, differential":1,
"Ovary disease":1,
"Clinicopathological":1,
"Cribriform morular variant":1,
"Molecular feature":1,
"Acute suppurative thyroiditis":1,
"Bacterial infection":1,
"Malignant tumor":1,
"Piriform sinus fistula":1,
"Differentiated thyroid cancer":2,
"FOXE1":1,
"Gene polymorphism":1,
"CD56":1,
"Diagnostic test accuracy review":1,
"G protein":1,
"Gnas":1,
"Gsα":1,
"thyroglobulin-Cre":1,
"Neoplasms":1,
"Republic of Korea":1,
"Ki67":1,
"malignancy":1,
"subtype":1,
"Cosmesis":1,
"double primary cancer":1,
"hybrid-type endoscopic thyroidectomy":1,
"Graves’ disease":1,
"autoimmune thyroid disease":1,
"hyperthyroidism":2,
"incidental thyroid carcinoma":1,
"Larynx":1,
"Neoplasm invasion":1,
"MUC1":1,
"extrathyroid extension":1,
"Keywoeds Recurrent laryngeal nerve":1,
"vocal functions":1,
"CCNE2":1,
"CDK6":1,
"CDKN1A":1,
"KIAA0101":1,
"Sp1":1,
"T3-thyrotoxicosis":1,
"functional thyroid carcinoma":1,
"hypercalcemia":1,
"Extranodal extension":1,
"Linc00518":1,
"LncRNA":1,
"MRP1":1,
"MiR-199a":1,
"Multidrug resistance":1,
"active surveillance":1,
"radioactive iodine":1,
"thyroid lobectomy":1,
"function recovery":1,
"recurrent laryngeal nerve":1,
"BRAF mutations":1,
"RAS mutations":1,
"infiltrative/diffusing follicular variant of papillary thyroid cancer":1,
"invasive encapsulated follicular variant of papillary thyroid carcinoma":1,
"iodine-metabolizing genes":1,
"papillary thyroid carcinoma with tall cell histology":1,
"prevalence":1,
"Airway Management":1,
"Case Report":1,
"Emergency Medicine":1,
"Malaysia":1,
"Stridor":1,
"Tracheostomy":1,
"head and neck surgery":1,
"neck abscess":1,
"thyroid abscess":1,
"Hemithyroidectomy":1,
"trachea":1,
"Hashimoto thyroiditis":1,
"Bisphenol":1,
"Endocrine disrupting chemical":1,
"Head and neck cancer":1,
"Oral cancer":1,
"Oropharyngeal cancer":1,
"cricoarytenoid unit":1,
"laryngeal cancer":1,
"magnetic resonance imaging":1,
"posterior laryngeal compartment":1,
"surface coils":1,
"Iodine distribution":1,
"nuclear accident":1,
"Cell growth":1,
"Huangqi Fuzheng decoction":1,
"Osteosarcoma":1,
"Systems pharmacology":1,
"ESCRT":1,
"Extracellular vesicles":1,
"Human hepatoma":1,
"MVB":1,
"GAS5":1,
"methylation":1,
"triple-negative breast cancer":1,
"CD4":1,
"CD8":1,
"Hashimoto’s thyroiditis":1,
"tumor-infiltrating lymphocytes":1,
"CTNNB1 mutations":1,
"desmoid tumor":1,
"desmoid-type fibromatosis":1,
"β-catenin aberrant staining":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2018年5月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
